Steven J. Rice - Nov 30, 2021 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Signature
/s/ Howard Horn, Attorney-in-Fact
Stock symbol
VIR
Transactions as of
Nov 30, 2021
Transactions value $
-$372,400
Form type
4
Date filed
12/2/2021, 04:12 PM
Previous filing
Aug 24, 2021
Next filing
Feb 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Options Exercise $128K +10K +48.54% $12.76 30.6K Nov 30, 2021 Direct F1
transaction VIR Common Stock Sale -$500K -10K -32.68% $50.00 20.6K Nov 30, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIR Employee Stock Option (Right to Buy) Options Exercise $0 -10K -2.3% $0.00 424K Nov 30, 2021 Common Stock 10K $12.76 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 600 shares of common stock acquired by the reporting person on November 30, 2021 pursuant to an employee stock purchase program.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021.
F3 1/4 of the shares subject to the stock option vest and become exercisable on September 15, 2020, and the remainder vest in 36 equal monthly installments thereafter.